Meeting
2020 ASCO Virtual Scientific Program
Circulating tumor DNA (ctDNA) to evaluate stage III and stage IV metastatic breast cancer (MBC), describe tumor heterogeneity, and outcome.
Authors
Qiang Zhang
Northwestern University, Department of Medicine, Division of Hematology/Oncology, Lurie Cancer Center, Chicago, IL
Qiang Zhang , Zheng Cai , Lorenzo Gerratana , Andrew A. Davis , Saya Jacob , Paolo D’Amico , Elena Vagia , Youbin Zhang , Wenan Qiang , Firas Wehbe , Katy Lucretia Kerby , Lisa E. Flaum , Ami N. Shah , Amir Behdad , William John Gradishar , Leonidas C. Platanias , Massimo Cristofanilli
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Metastatic
Track
Breast Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 38: 2020 (suppl; abstr 1028)
DOI
10.1200/JCO.2020.38.15_suppl.1028
Abstract #
1028
Poster Bd #
113
Abstract Disclosures
Similar Posters
First Author: Sandra Algaze
Poster
2018 ASCO Annual Meeting
Real-time circulating tumor DNA profiling of advanced cholangiocarcinoma (CCA).
First Author: Kabir Mody
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2017 ASCO Annual Meeting
Genomic profiling of circulating tumor DNA (ctDNA) from patients (pts) with metastatic breast cancer (mBC).
First Author: Lajos Pusztai